Trial Profile
A real world experience to evaluate the efficacy of Omalizumab in patients with Severe Asthma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2016
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 09 Nov 2016 New trial record